fbpx
close read more

About Servier

Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2021, Servier employs 21,800 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities.

A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neuroscience and immuno-inflammatory diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.

Press contact :

01.55.72.70.10 – presse@servier.com

Press release

Press release
07/09/2021
Servier and Neurochlore announce the main results of the two phase 3 clinical studies assessing bumetanide in the treatment of Autism Spectrum Disorders in children and adolescents
Press release
25/08/2021
Servier and OSE Immunotherapeutics Announce Enrollment of First Patient in OSE-127/S95011 Phase 2 Clinical Trial in Sjögren’s Syndrome
Press release
12/07/2021
Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
Press release
23/06/2021
Servier partners with BioLabs Global to open an incubator in Paris-Saclay for early stage life science companies
Press release
16/06/2021
Servier and PRISM BioLab enter drug discovery collaboration for a novel target
Press release
14/06/2021
Servier and Oncodesign announce the selection of a preclinical candidate as part of their collaboration targeting new treatments for Parkinson’s disease
Press release
31/05/2021
Servier appoints Bertrand Renaud as Chief Patient Officer
Press release
27/05/2021
The Campus Biotech Digital joins forces with Atos, IBM and Microsoft to develop a unique training platform
Press release
26/05/2021
Béatrice Bihr joins the Servier Group as Executive Vice President General Secretariat and member of the Group Executive Committee